Showing 6,661 - 6,680 results of 81,313 for search '(( 2 we decrease ) OR ( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 6661

    Discovery of D25, a Potent and Selective MNK Inhibitor for Sepsis-Associated Acute Spleen Injury by Qiang Li (8118)

    Published 2024
    “…This study undertakes the modification of a 4-(3-(piperidin-4-yl)-1<i>H</i>-pyrazol-5-yl)pyridine structure, leading to the discovery of 4-(3-(piperidin-4-yl)-1<i>H</i>-pyrazol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (D25) as a potent and selective MNK inhibitor. …”
  2. 6662

    Plausibility of the zebrafish embryos/larvae as an alternative animal model for autism: A comparison study of transcriptome changes by Sangwoo Lee (1727713)

    Published 2018
    “…Specifically, we exposed zebrafish to valproic acid (0, 12.5, 25, 50, or 100 μM), which is a chemical known to induce autism-like effects. …”
  3. 6663
  4. 6664
  5. 6665
  6. 6666
  7. 6667
  8. 6668

    Strains and plasmids used in this study. by Javiera Norambuena (137228)

    Published 2023
    “…We demonstrate that Prs is inhibited by Cu ions <i>in vivo</i> and <i>in vitro</i> and that treatment of cells with Cu(II) results in decreased PRPP levels. …”
  9. 6669

    DataSheet_2_The gut microbiota as a potential biomarker for methamphetamine use disorder: evidence from two independent datasets.pdf by Linzi Liu (9386378)

    Published 2023
    “…Background<p>Methamphetamine use disorder (MUD) poses a considerable public health threat, and its identification remains challenging due to the subjective nature of the current diagnostic system that relies on self-reported symptoms. …”
  10. 6670

    <i>S</i>. <i>aureus</i> PRPP utilizing enzymes. by Javiera Norambuena (137228)

    Published 2023
    “…We demonstrate that Prs is inhibited by Cu ions <i>in vivo</i> and <i>in vitro</i> and that treatment of cells with Cu(II) results in decreased PRPP levels. …”
  11. 6671
  12. 6672
  13. 6673
  14. 6674
  15. 6675

    Schematic illustrating the study procedures. by Yuki Asai (15190606)

    Published 2023
    “…Subsequently, the PD rate was compared during a period of two years and 6 months between the pre-PBPM (n = 39) and post-PBPM (n = 62). …”
  16. 6676
  17. 6677

    PRISMA checklist. by Giacomo Stroffolini (11716410)

    Published 2023
    “…<i>stercoralis</i> prevalence after PC: prevalence Risk Ratio (RR) 0.18 (95% CI 0.14–0.23), I<sup>2</sup> = 0. A similar trend was observed in studies that used serology for diagnosis: RR 0.35 (95% CI 0.26–0.48), I<sup>2</sup> = 4.25%. …”
  18. 6678

    PRISMA flow diagram. by Giacomo Stroffolini (11716410)

    Published 2023
    “…<i>stercoralis</i> prevalence after PC: prevalence Risk Ratio (RR) 0.18 (95% CI 0.14–0.23), I<sup>2</sup> = 0. A similar trend was observed in studies that used serology for diagnosis: RR 0.35 (95% CI 0.26–0.48), I<sup>2</sup> = 4.25%. …”
  19. 6679

    Main characteristics of included papers. by Giacomo Stroffolini (11716410)

    Published 2023
    “…<i>stercoralis</i> prevalence after PC: prevalence Risk Ratio (RR) 0.18 (95% CI 0.14–0.23), I<sup>2</sup> = 0. A similar trend was observed in studies that used serology for diagnosis: RR 0.35 (95% CI 0.26–0.48), I<sup>2</sup> = 4.25%. …”
  20. 6680

    Supplementation. by James Phelan (354237)

    Published 2024
    “…This is compared to Public Health England’s (PHE) stipulated normal levels of 60% during winter. 81.2% had a level less than 75nmol/L, with 51.2% less than 50nmol/L and 6.6% less than 25nmol/L. …”